Hajioff D, Raut V V, Walsh R M, Bath A P, Bance M L, Guha A, Tator C H, Rutka J A
Clin Otolaryngol. 2008 Jun;33(3):255-9. doi: 10.1111/j.1749-4486.2008.01705.x.
Seventy-two patients with a unilateral vestibular schwannoma have been treated conservatively for a median of 121 months. They have been followed prospectively by serial clinical examination, MRI scans and audiometry. Twenty-five patients (35%, 95% CI: 24-47) failed conservative management and required active intervention during the study. No factors predictive of tumour growth or failure of conservative management could be identified. Seventy-five per cent of failures occurred in the first half of the 10-year study. The median growth rate for all tumours at 10 years was 1 mm/year (range -0.53-7.84). Cerebellopontine angle tumours grew faster (1.4 mm/year) than intracanalicular tumours (0 mm/year, P < 0.01); 92% had growth rates under 2 mm/year. Hearing deteriorated substantially even in tumours that did not grow, but did so faster in tumours that grew significantly (mean deterioration in pure tone average at 0.5, 1, 2 and 3 kHz was 36 dB; speech discrimination scores deteriorated by 40%). Patients who failed conservative management had clinical outcomes that were not different from those who underwent primary treatment without a period of conservative management.
72例单侧前庭神经鞘瘤患者接受了中位时间为121个月的保守治疗。通过系列临床检查、MRI扫描和听力测定对他们进行了前瞻性随访。25例患者(35%,95%可信区间:24 - 47)保守治疗失败,在研究期间需要积极干预。未发现预测肿瘤生长或保守治疗失败的因素。75%的治疗失败发生在10年研究的前半段。所有肿瘤在10年时的中位生长速率为1毫米/年(范围 -0.53 - 7.84)。桥小脑角肿瘤生长更快(1.4毫米/年),高于内听道肿瘤(0毫米/年,P < 0.01);92%的肿瘤生长速率低于2毫米/年。即使在未生长的肿瘤中听力也有显著下降,但在显著生长的肿瘤中下降更快(0.5、1、2和3千赫兹处纯音平均听阈的平均下降为36分贝;言语识别分数下降了40%)。保守治疗失败的患者的临床结果与未经过一段保守治疗而直接接受初始治疗的患者并无差异。